Lynne  Ward net worth and biography

Lynne Ward Biography and Net Worth

Director Since: August 2019
Committees: Audit (Chair); Environmental, Social & Governance; Finance
Other Public Boards: None
Education: B.S. Accounting, University of Utah
Certified Public Accountant

Career Highlights
– Executive Director, my529 (formerly known as the Utah Educational Savings Plan), offering municipal fund securities, 2004 to 2019. Underlying investments were with Vanguard, Dimensional, PIMCO, Sallie Mae Bank and U.S. Bank.
– Member of the University of Utah’s Investment Advisory Committee, 2018 to present
– Member of the Board of Directors of the Blue Healthcare Bank, 2007 to 2009
– Member of the Board of Directors of Stampin’ Up!, 2010 to 2016
– Utah Chapter NACD Board of Directors, 2017 to present
– Walker Institute at Weber State University board of directors, 2012 to present
– Senior leader and advisor to Utah governors Olene S. Walker and Michael O. Leavitt
– Senior leader for Utah state government’s central accounting office and State Auditor’s Office

Qualifications of Particular Relevance to Merit
Ward was the Executive Director of my529 (formerly Utah Educational Savings Plan), the nation’s largest state-run college savings plan offering municipal fund securities. Under her leadership, my529’s assets under management have grown from approximately $950 million in approximately 48,000 accounts to approximately $14 billion in approximately 400,000 accounts. At my529, a consistently top-rated plan, Ward established the organization’s growth strategy. She oversaw execution of investment offerings, IT development, federal and state legislative affairs, cybersecurity, audits, customer service and marketing. Ward, a Certified Public Accountant, served as a senior leader and advisor to Utah governors Olene S. Walker and Michael O. Leavitt. She has extensive for-profit and non-profit board experience which includes Stampin’ Up! Inc., Blue Healthcare Bank, the University of Utah Investment Advisory Committee and the Utah Chapter National Association of Corporate Directors.

What is Lynne Ward's net worth?

The estimated net worth of Lynne Ward is at least $625,146.48 as of March 8th, 2023. Ms. Ward owns 5,964 shares of Merit Medical Systems stock worth more than $625,146 as of December 3rd. This net worth approximation does not reflect any other assets that Ms. Ward may own. Learn More about Lynne Ward's net worth.

How do I contact Lynne Ward?

The corporate mailing address for Ms. Ward and other Merit Medical Systems executives is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. Merit Medical Systems can also be reached via phone at (801) 253-1600 and via email at [email protected]. Learn More on Lynne Ward's contact information.

Has Lynne Ward been buying or selling shares of Merit Medical Systems?

Lynne Ward has not been actively trading shares of Merit Medical Systems over the course of the past ninety days. Most recently, Lynne Ward sold 11,585 shares of the business's stock in a transaction on Wednesday, March 8th. The shares were sold at an average price of $66.71, for a transaction totalling $772,835.35. Following the completion of the sale, the director now directly owns 5,964 shares of the company's stock, valued at $397,858.44. Learn More on Lynne Ward's trading history.

Who are Merit Medical Systems' active insiders?

Merit Medical Systems' insider roster includes A. Anderson (Director), Jill Anderson (Director), David Floyd (Director), Ronald Frost (COO), Thomas Gunderson (Director), Fred Lampropoulos (Founder, Chairman and CEO), Brian Lloyd (Insider), F. Millner (Director), Raul Parra, Jr. (CFO), Neil Peterson (COO), Michel Voigt (Insider), Lynne Ward (Director), and Joseph Wright (Insider). Learn More on Merit Medical Systems' active insiders.

Are insiders buying or selling shares of Merit Medical Systems?

In the last twelve months, insiders at the medical instruments supplier sold shares 8 times. They sold a total of 131,783 shares worth more than $11,203,323.63. The most recent insider tranaction occured on November, 15th when Director F. Ann Millner sold 12,500 shares worth more than $1,269,375.00. Insiders at Merit Medical Systems own 3.7% of the company. Learn More about insider trades at Merit Medical Systems.

Information on this page was last updated on 11/15/2024.

Lynne Ward Insider Trading History at Merit Medical Systems

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/8/2023Sell11,585$66.71$772,835.355,964View SEC Filing Icon  
9/15/2021Sell9,470$71.83$680,230.1021,969View SEC Filing Icon  
See Full Table

Lynne Ward Buying and Selling Activity at Merit Medical Systems

This chart shows Lynne Ward's buying and selling at Merit Medical Systems by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Merit Medical Systems Company Overview

Merit Medical Systems logo
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
Read More

Today's Range

Now: $104.82
Low: $104.06
High: $105.56

50 Day Range

MA: $99.26
Low: $93.76
High: $105.33

2 Week Range

Now: $104.82
Low: $65.46
High: $106.87

Volume

405,499 shs

Average Volume

436,406 shs

Market Capitalization

$6.11 billion

P/E Ratio

51.38

Dividend Yield

N/A

Beta

0.84